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Diagnosis
Silent ischemiaCoronary artery spasm plays an important role in the
pathogenesis of coronary artery disease and has been shown to
be associated with adverse clinical outcomes, including acute
coronary syndrome, heart failure, ventricular arrhythmias, and
sudden cardiac death [1–5]. In particular, multivessel spasm has
been reported to be a strong predictor of major adverse cardiac
events in patients with vasospastic angina [1]. In this issue of the
journal, Sueda et al. [6] report a patient in whom multivessel
spasm was documented by acetylcholine provocation test, despite
no symptoms suggestive of myocardial ischemia. Because coronary
artery spasm can be associated with adverse events even if it is
silent [4,5], its diagnosis is crucial.
Vasospastic angina is usually suspected based on symptoms, and
noninvasive evaluations are the ﬁrst step in its diagnosis. Because
coronary artery spasm develops transiently, its diagnosis can be
challenging in a clinical setting. Holter recording is a useful and
important examination not only for the detection of ischemic attacks
but also for estimating the frequency of such attacks [3,7]. Because
its frequency can considerably ﬂuctuate, Holter recording (multi-
channel recording desirable) repeated or for an extended period of
time of 24–48 h can improve diagnostic accuracy [3]. In the present
patient, data regarding Holter recording were not shown, but
inferior ischemia was suspected on exercise tolerance testing. The
results of exercise testing in patients with vasospastic angina have
been shown to be inﬂuenced by the degree of disease activity [3,8]
and are characterized by poor reproducibility caused by circadian
variations in exercise tolerance. Importantly, the present patient
had no symptoms suggestive of myocardial ischemia, i.e. chest pain/
discomfort. Even symptoms of the jaw, throat, neck, back, shoulder,
arms, and epigastric region were absent. The authors speculated
that slight fatigue and cold sweating might be symptoms related
to coronary artery spasm; however, objective evidence supporting
this speculation is lacking. Caution is required because some
patients with silent myocardial ischemia associated with multi-
vessel spasm have no symptoms suggestive of myocardial ischemia,
such as the present patient.
The underlying mechanism of silent myocardial ischemia
remains unclear; however, several factors, such as differences in
both peripheral and central neural processing of pain, autonomicDOI of original article: http://dx.doi.org/10.1016/j.jccase.2015.02.003
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to play important roles in the pathogenesis of silent ischemia.
It has been also reported that coronary collaterals immediately
appear during coronary occlusion due to coronary artery spasm
in patients with variant angina, and such collateral ﬂow could
prevent transmural myocardial ischemia, resulting in a lesser
degree of ischemia [9]. In patients with vasospastic angina, chest
pain accompanies about 20% to 30% of episodes of ischemic ST-T
changes, and many episodes of coronary spasm are asymptomatic
[3]. Egashira et al. [7] reported that the majority (76%) of ischemic
events are completely silent in patients with variant angina.
Coronary angiography was performed in the present patient.
Recently, the use of coronary computed tomography angiography to
evaluate coronary artery disease has been increasing annually in
Japan. Because coronary artery spasm cannot be diagnosed on
coronary computed tomography angiography, coronary angiogra-
phy must be performed in patients suspected to have coronary
artery spasm. A drug-induced coronary spasm provocation test
during coronary angiography has been established to be a useful
diagnostic examination for coronary artery spasm [1,3,10]. Acetyl-
choline and ergonovine are most often used clinically as pharmaco-
logical agents in coronary spasm provocation tests in Japan.
However, these tests are thought to have a potential risk of
arrhythmic complications, including ventricular tachycardia, ven-
tricular ﬁbrillation, and bradyarrhythmias. A recent observational
study evaluating 1244 patients with vasospastic angina who
underwent coronary spasm provocation tests (acetylcholine 57%
and ergonovine 40%) has reported that the overall incidence of
arrhythmic complications was 6.8%, which is comparable to the 7.0%
incidence during spontaneous angina events [1]. Furthermore, this
study has also shown that mixed (focal and diffuse) type multivessel
spasm was associated with major adverse cardiac events [1]. Thus,
coronary spasm provocation tests are relatively safe and may be
useful for risk stratiﬁcation in patients with vasospastic angina.
However, the Japan Circulation Society (JCS) guidelines recommend
that acetylcholine or ergonovine provocation tests should be
performed during coronary angiography in patients suspected to
have vasospastic angina on the basis of symptoms, but who have not
been diagnosed with coronary spasm by noninvasive evaluation
(Class I) [3]. Detailed history taking is important in the diagnosis of
coronary artery spasm. Because the incidence of vasospastic angina
is higher in Japanese than in Westerners, the potential possibility
of coronary artery spasm should be kept in mind when performing
history taking and noninvasive evaluations, and it is important to
assess the need for spasm provocation tests.
The ﬁnal problem is terminology. The authors diagnosed ‘‘silent
coronary spastic angina’’ in the present case. However, because a
diagnosis of ‘‘angina’’ is based on the subjective evaluation of reserved.
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a diagnosis of ‘‘silent myocardial ischemia due to coronary artery
spasm’’. More importantly, the second is that the evidence
supporting a diagnosis of silent myocardial ischemia was weak.
In the present patient, the diagnosis of silent myocardial ischemia
requires the objective ﬁndings such as a decrease in ischemic
attacks with ST-T changes on Holter recording or the improvement
of inferior ischemia on thallium exercise scintigraphy after starting
treatment with a calcium-channel antagonist as compared with
before treatment. However, the present case provides many
informative suggestions with regard to the difﬁculty in medical
history taking and the diagnosis of silent myocardial ischemia
due to coronary artery spasm.
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